These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria. Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229 [TBL] [Abstract][Full Text] [Related]
3. Cardioprotective Effects of the Novel Compound Vastiras in a Preclinical Model of End-Organ Damage. Altara R; da Silva GJJ; Frisk M; Spelta F; Zouein FA; Louch WE; Booz GW; Cataliotti A Hypertension; 2020 May; 75(5):1195-1204. PubMed ID: 32200677 [TBL] [Abstract][Full Text] [Related]
5. Endothelial dysfunction and cardiorenal injury in experimental salt-sensitive hypertension: effects of antihypertensive therapy. Hayakawa H; Coffee K; Raij L Circulation; 1997 Oct; 96(7):2407-13. PubMed ID: 9337217 [TBL] [Abstract][Full Text] [Related]
6. Hypertension and Organ Damage in Women. Muiesan ML; Paini A; Aggiusti C; Bertacchini F; Rosei CA; Salvetti M High Blood Press Cardiovasc Prev; 2018 Sep; 25(3):245-252. PubMed ID: 29943358 [TBL] [Abstract][Full Text] [Related]
7. RAAS inhibition and cardiorenal syndrome. Onuigbo MA Curr Hypertens Rev; 2014; 10(2):107-11. PubMed ID: 25549841 [TBL] [Abstract][Full Text] [Related]
8. [Organ damage and cardiorenal syndrome in acute heart failure]. Casado Cerrada J; Pérez Calvo JI Med Clin (Barc); 2014 Mar; 142 Suppl 1():26-31. PubMed ID: 24930080 [TBL] [Abstract][Full Text] [Related]
9. Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension. Shigematsu Y; Hamada M; Mukai M; Matsuoka H; Sumimoto T; Hiwada K J Hypertens; 1995 Jan; 13(1):155-60. PubMed ID: 7759846 [TBL] [Abstract][Full Text] [Related]
10. Cardiorenal syndrome: pathophysiological mechanism, preclinical models, novel contributors and potential therapies. Fu Q; Cao L; Li H; Wang B; Li Z Chin Med J (Engl); 2014; 127(16):3011-8. PubMed ID: 25131243 [TBL] [Abstract][Full Text] [Related]
19. The renin-angiotensin-aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states. Brewster UC; Setaro JF; Perazella MA Am J Med Sci; 2003 Jul; 326(1):15-24. PubMed ID: 12861121 [TBL] [Abstract][Full Text] [Related]
20. Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension. Cerasola G; Cottone S; Mulé G; Nardi E; Mangano MT; Andronico G; Contorno A; Li Vecchi M; Galione P; Renda F; Piazza G; Volpe V; Lisi A; Ferrara L; Panepinto N; Riccobene R J Hypertens; 1996 Jul; 14(7):915-20. PubMed ID: 8818932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]